This on-demand webinar is part of the Pharmacist to Pharmacist Buprenorphine Resource Initiative for Dispensing Guidance and Education (P2P BRIDGE) series. The goal of this webinar is to help Kentucky pharmacists learn more about the science and evidence behind medications for opioid use disorder (MOUD) and the role community pharmacies can play in helping patients maintain remission and recovery.
This webinar is a recording of a live broadcast presented on May 16, 2024. Participants who claimed CE for the live broadcast are not eligible to claim CE credit for the recorded webinar.
|
This ACPE-accredited continuing pharmacy education activity (0022-0000-24-017-H08-P) is designed to meet the Kentucky Board of Pharmacy continuing education regulatory requirement for pharmacists to complete 1 hour of CPE on the opioid epidemic or opioid use disorder as outlined in 201 KAR 2:015.
|
Faculty
|
|
|
| Mark J. Huffmyer was a board-certified ambulatory care, geriatric, anticoagulation, and multiple sclerosis pharmacist. He served as the clinical coordinator for the Neurology and Psychiatry/Substance-Use-Disorder teams at the University of Kentucky Healthcare Specialty Pharmacy and Infusion Services. He was an adjunct assistant professor at the UK College of Pharmacy (UKCOP). He graduated from the UKCOP in May 2014 and completed a residency at UKCOP/Wheeler’s Pharmacy/American Pharmacy Service Corporation Community Pharmacy Residency in 2015. He was passionate about teaching and precepted a variety of learners including pharmacy students, residents, and international students. He conducted research through the Sanders-Brown Center of Aging in geriatrics, cognitive impairment, polypharmacy, and deprescribing. | |
 Julie B. Perry, DNP, PMHNP-BC, FNP-BC
Assistant Professor
University of Kentucky College of Nursing
Lexington, KY
|
|
|
Julie B. Perry is a family and psychiatric-mental health nurse practitioner who has worked for over 25 years in psychiatric and community health treating patients across the lifespan for acute and chronic medical, mental, and substance use disorders.
|
|
Content Reviewer
Jessica Johnson, PharmD
Clinical Pharmacist Practitioner
Substance Use Disorder and Mental Health
Robley Rex Veterans Affairs Medical Center
Louisville, KY
Disclosures
None of the planners, authors, reviewers, or others in control of educational content for this activity have any relevant financial relationships with ineligible companies to disclose.
Learning Objectives
- Describe the risk factors for and pathophysiology of nonmedical use of opioids and opioid use disorder (OUD).
- Review mechanisms of action and clinical trial data for medications for opioid use disorder (MOUD).
- Discuss guideline recommendations and goals for buprenorphine treatment for OUD.
- Explain the role of pharmacy staff in treatment retention and long-term outcomes for patients taking buprenorphine.
Agenda
- On-demand Webinar Presentation (50 min)
- Post-test and Evaluation (10 min)
Requirements for CE Credit
To claim credit for this activity, participants must:
1. Watch the on-demand webinar in its entirety
2. Pass the post-test with a score of 70% or higher
3. Complete the activity evaluation
Upon successful completion participant CE credit will be directly uploaded to CPE Monitor.
Please be sure to verify your NABP e-Profile ID and date of birth (month/day) are correct under your learner profile in Learning Express prior to submitting your evaluation.
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Support
The Buprenorphine Resource Initiative for Dispensing Guidance and Education (BRIDGE) is funded by a grant from the Foundation for Opioid Response Efforts (https://forefdn.org). For more information regarding P2P BRIDGE visit https://p2p.uky.edu/bridge.
System Requirements
Please ensure the computer system you plan to use meets the following minimum requirements:
- Operating System: Windows 10 or higher, macOS Sierra (10.12) or higher
- Internet Browser: Chrome 30 or higher, Firefox 27 or higher, Microsoft Edge, Safari 9 or higher
- Internet connection: Cable, High-speed DSL, and any other medium that is internet accessible
- Media Viewing Requirements: Adobe Reader, HTML5
Click to view our privacy policy
Education Disclaimer
The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, legal/regulatory issues and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice. Activities accredited by the University of Kentucky College of Pharmacy are intended solely for purposes of supplementing health care professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Kentucky College of Pharmacy.
For questions regarding this activity, please contact the UK CoP Continuing Professional Development Office at pharmacyCPD@uky.edu